Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Monalizumab
Trade Name
Synonyms NN-8765|IPH-2201|IPH 2201|IPH2201
Drug Descriptions

Monalizumab (IPH2201) is a humanized monoclonal antibody against NKG2A that blocks NKG2A ligand binding, which in turn induces cell-mediated immune response against cancer cells (PMID: 30503213, PMID: 31623687, PMID: 31308062).

CAS Registry Number 1228763-95-8
NCIT ID C120208


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cetuximab + Monalizumab Cetuximab Monalizumab 0 2
Durvalumab + Fluorouracil + Leucovorin + Monalizumab + Oxaliplatin Durvalumab Fluorouracil Leucovorin Monalizumab Oxaliplatin 0 1
Durvalumab + Monalizumab Durvalumab Monalizumab 0 6
Ibrutinib + Monalizumab Ibrutinib Monalizumab 0 1
Monalizumab Monalizumab 0 2

Additional content available in CKB BOOST